Exelixis
EXEL
#1647
Rank
โ‚ฌ11.56 B
Marketcap
46,00ย โ‚ฌ
Share price
-5.25%
Change (1 day)
43.06%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company